Please assess the completion status of the following clinical trial:

Trial Title: Early Detection and Intervention for the Prevention of Psychosis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects in the age range of 12-25 and living in the experimental catchment area may be enrolled in the EDIPP study based on meeting at least one of the inclusion requirements AND none of the exclusion criteria;~* Screening process indicates symptoms equivalent to a minimum rating of '1' on at least one positive symptom of psychosis;~* Screening process indicates a likely family history of first degree relative with psychotic illness plus a deterioration in functioning equivalent to a 30% drop in functioning score over the past year; OR~* Screening process indicates a likely history of schizotypal personality disorder plus a deterioration in functioning equivalent to a 30% drop in functioning over the past year.~Exclusion Criteria:~* Outside the age range of 12 to 25 years;~* History of intelligence quotient (IQ) below 70 (based on school records, not tested at PIER);~* More than one month duration of psychosis (guided by the criteria of at least one 6 on the Positive Symptom sub-scale of the Scale of Positive Symptoms (SOPS);~* History of previous psychotic episode, whether or not treatment was received;~* Taken antipsychotic medication for more than 30 days at a therapeutic dose for psychotic symptoms;~* Either the young person being screened for the study or both parents do not speak proficient English;~* Female is pregnant at baseline (inquired on the screening interview); AND~* Subject is a prisoner.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 25 Years
- Healthy Volunteers: f

Study Arms:
- Control group (Type: NO_INTERVENTION): This is the control arm. Participants will be offered only case management. Participants may seek outside treatment, without guidance from study staff.
- Family-aided Assertive Community Treatment (Type: EXPERIMENTAL): This is the experimental intervention arm for high-risk-for-psychosis participants. The intervention includes psychiatric drugs (aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine), psychoeducational multifamily group treatment and supported employment and education .

Based on this trial design, predict the completion outcome and termination type (if applicable).